Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

289

HTML

2642

Figures (1-4)

239

Tables (1-2)

174

Sum=3344

Sep 28, 2006 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. Sep 28, 2006; 12(36): 5798-5804
Published online Sep 28, 2006. doi: 10.3748/wjg.v12.i36.5798

Full Size Figure Download Figure

Figure 1 Effect of BPB on cysteamine-induced duodenal ulcers in rats. ^bP < 0.001 vs BPB 0 mg/kg (cysteamine only) (Dunnett's test).

Citation: Tariq M, Elfaki I, Khan HA, Arshaduddin M, Sobki S, Moutaery MA. Bromophenacyl bromide, a phospholipase A₂ inhibitor attenuates chemically induced gastroduodenal ulcers in rats. World J Gastroenterol 2006; 12(36): 5798-5804
URL: https://www.wjgnet.com/1007-9327/full/v12/i36/5798.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i36.5798